Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy.
Tara CochraneAlicia EnricoGuillermo José Ruiz ArgüellesEvgueniy HadjievEwa Lech-MarandaTamas MassziEugene A NikitinTadeusz RobakRobert WeinkoveShang-Ju WuBeenish S ManzoorTodd BusmanMadhavi PaiViktor KomlosiMary Ann AndersonPublished in: Leukemia & lymphoma (2023)
Keyphrases
- chronic lymphocytic leukemia
- acute lymphoblastic leukemia
- phase iii
- acute myeloid leukemia
- open label
- study protocol
- electronic health record
- multiple myeloma
- phase ii
- diffuse large b cell lymphoma
- hodgkin lymphoma
- clinical trial
- combination therapy
- big data
- randomized controlled trial
- machine learning
- artificial intelligence